Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Subcostal single-port robot-assisted resection of a posterior mediastinal tumor in an infant.

General thoracic and cardiovascular surgery·2026
Same author

Complete Resection of a Middle Mediastinal Malignant Peripheral Nerve Sheath Tumour via a Transmanubrial Osteomuscular Sparing Approach: A Case Report.

Respirology case reports·2026
Same author

Preoperative sarcopenia diagnosed based on the asian working group criteria and Short-term outcomes in older patients undergoing resection of early-stage non-small cell lung cancer.

Surgery today·2026
Same author

Light-induced acceleration of specific binding between CEACAM-5 and antibodies for early detection of colorectal cancer.

Nanoscale horizons·2026
Same author

Loss of PTEN as an Independent Poor Prognosis Indicator in Lung Adenocarcinoma, but Not in Squamous Cell Carcinoma, Is Associated with an Immunosuppressive Tumor Microenvironment and Distinct Co-Mutational Profiles.

Medical sciences (Basel, Switzerland)·2026
Same author

Development of a model to predict high-risk histopathological features in early T-stage lung adenocarcinoma using thin-slice CT and FDG-PET/CT parameters for selecting optimal candidates for sub-lobar resection.

Journal of thoracic disease·2026

Related Experiment Video

Updated: Jul 2, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.5K

Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma.

Mei-Chee Tai1, Leonidas E Bantis2, Gargy Parhy1

  • 1Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

International Journal of Molecular Sciences
|February 24, 2024
PubMed
Summary
This summary is machine-generated.

A new circulating microRNA (miRNA) panel can predict recurrence in early-stage lung adenocarcinoma (LUAD). This noninvasive tool helps identify patients who may benefit from adjuvant chemotherapy, improving treatment efficacy.

Keywords:
lung adenocarcinomamicroRNAplasmarecurrencesurvival

More Related Videos

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.7K
Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.1K

Related Experiment Videos

Last Updated: Jul 2, 2025

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

5.5K
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

15.7K
Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
08:49

Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool

Published on: May 27, 2016

11.1K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Early-stage lung adenocarcinoma (LUAD) patients face significant recurrence risks.
  • Current biomarkers are insufficient for identifying early-stage LUAD patients who would benefit from adjuvant chemotherapy.

Purpose of the Study:

  • To identify circulating microRNAs (miRNAs) for predicting recurrence in early-stage LUAD.
  • To develop a noninvasive biomarker panel for risk stratification and treatment decisions.

Main Methods:

  • MiRNA microarray analysis of plasma samples from stage I LUAD patients with known recurrence outcomes.
  • Validation of a three-miRNA panel (miR-23a-3p, miR-320c, miR-125b-5p) in independent patient cohorts.
  • Statistical analysis to assess the panel's predictive performance for recurrence and survival.

Main Results:

  • A circulating miRNA panel comprising miR-23a-3p, miR-320c, and miR-125b-5p was developed.
  • The panel achieved an AUC of 0.776 in predicting recurrence in stage I LUAD.
  • In an independent test set, the panel showed an AUC of 0.804 and was an independent predictor of disease-free and overall survival.

Conclusions:

  • The developed circulating miRNA panel is a promising noninvasive tool for stratifying early-stage LUAD patients.
  • This biomarker panel can aid in determining optimal adjuvant chemotherapy strategies.
  • Improved patient stratification may lead to enhanced treatment efficacy and better survival outcomes.